SciBase Holding AB (publ) (STO:SCIB)

Market Cap	162.38M +21.4%
Revenue (ttm)	52.40M +51.2%
Net Income	-96.85M
EPS	-14.64
Shares Out	14.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,335
Open	12.05
Previous Close	12.20
Day's Range	11.50 - 12.10
52-Week Range	11.50 - 54.00
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 50
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SCIB

Financial Performance

In 2025, SciBase Holding AB's revenue was 40.46 million, an increase of 36.21% compared to the previous year's 29.71 million. Losses were -87.06 million, 32.8% more than in 2024.

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error